GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Semler Scientific Inc (STU:6FA) » Definitions » EV-to-EBITDA

Semler Scientific (STU:6FA) EV-to-EBITDA : 6.30 (As of Sep. 25, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Semler Scientific EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Semler Scientific's enterprise value is €131.62 Mil. Semler Scientific's EBITDA for the trailing twelve months (TTM) ended in Jun. 2024 was €20.90 Mil. Therefore, Semler Scientific's EV-to-EBITDA for today is 6.30.

The historical rank and industry rank for Semler Scientific's EV-to-EBITDA or its related term are showing as below:

STU:6FA' s EV-to-EBITDA Range Over the Past 10 Years
Min: -107.24   Med: 11.3   Max: 106.05
Current: 6.49

During the past 13 years, the highest EV-to-EBITDA of Semler Scientific was 106.05. The lowest was -107.24. And the median was 11.30.

STU:6FA's EV-to-EBITDA is ranked better than
82.33% of 481 companies
in the Medical Devices & Instruments industry
Industry Median: 14.7 vs STU:6FA: 6.49

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-09-25), Semler Scientific's stock price is €20.20. Semler Scientific's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was €1.888. Therefore, Semler Scientific's PE Ratio for today is 10.70.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Semler Scientific EV-to-EBITDA Historical Data

The historical data trend for Semler Scientific's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Semler Scientific EV-to-EBITDA Chart

Semler Scientific Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 26.96 36.75 29.01 10.00 10.51

Semler Scientific Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.64 4.68 10.51 5.73 10.07

Competitive Comparison of Semler Scientific's EV-to-EBITDA

For the Medical Devices subindustry, Semler Scientific's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Semler Scientific's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Semler Scientific's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Semler Scientific's EV-to-EBITDA falls into.



Semler Scientific EV-to-EBITDA Calculation

Semler Scientific's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=131.622/20.904
=6.30

Semler Scientific's current Enterprise Value is €131.62 Mil.
Semler Scientific's EBITDA for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €20.90 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Semler Scientific  (STU:6FA) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Semler Scientific's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=20.20/1.888
=10.70

Semler Scientific's share price for today is €20.20.
Semler Scientific's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €1.888.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Semler Scientific EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Semler Scientific's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Semler Scientific Business Description

Traded in Other Exchanges
Address
2340-2348 Walsh Avenue, Suite 2344, Santa Clara, CA, USA, 95051
Semler Scientific Inc is a US-based company that is engaged in providing technology solutions to improve the clinical effectiveness and efficiency of healthcare providers. It focuses on developing, manufacturing, and marketing proprietary products and services that assist customers, including insurance plans, physicians, and risk assessment groups, in evaluating and treating chronic diseases. The company markets its vascular-testing product under the QuantaFlo brand, which is a four-minute in-office blood flow test.

Semler Scientific Headlines

No Headlines